Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Omzey logo — company profile

Omzey

Founded 2017 Italy Italy 31 employees Convertible Note Total: $3.62M AI, Biotechnology +1

General Information

Company Name Omzey
Founded Year 2017
Location Italy Italy
Employees 31
Industries AI, Biotechnology, Health Care
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Omzey. To contact Omzey, visit omzey.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Omzey

Omzey is an Italian startup founded in 2017 with a focus on AI, Biotechnology, and Health Care industries. The company emerged from GenomeUp and was established by three visionary individuals with the aim of providing direct support to those dealing with patients with rare diseases. With the creation of JuliaOmix™, an innovative suite designed to expedite the diagnosis of rare diseases, Omzey has realized its initial dream. The company's rebranding to Omzey signifies its commitment to continuous growth and development. The new name serves as a homage to the world of omics sciences, drawing inspiration from the epic tale of the Odyssey. Omzey represents a transformative journey characterized by challenges, discoveries, and personal growth, mirroring the company's evolution since its inception. The most recent influx of funding for Omzey totaled €637.50K through a Convertible Note investment, which took place on 08 September 2023, marking a significant milestone in the company's financial journey. As the company strives for further expansion and progress, this latest injection of capital underscores its potential for future growth and impact within the realm of rare disease diagnosis and treatment.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note €637.50K -
08 Sep 2023
Convertible Note €1.15M 2
Lazio Innova Scientifica
Lazio Innova, Scientifica
15 Mar 2023
Seed Round €1.20M 8
Berkeley SkyDeck LVenture Group Italian Angels for Growth
Berkeley SkyDeck, LVenture Group +6
08 Feb 2022
Pre Seed Round €250.00K -
01 Jan 2020
Non Equity Assistance Undisclosed 1
Berkeley SkyDeck
Berkeley SkyDeck
01 Sep 2019
Pre Seed Round €300.00K 2
LVenture Group Italian Angels for Growth
LVenture Group, Italian Angels for Growth
06 Aug 2018
Pre Seed Round €80.00K 1
LVenture Group
LVenture Group
19 Dec 2017

FAQ About Omzey

OMZEY was born in 2017 from GenomeUp and the dream of three Italian guys. They wanted to directly support everyone who had to deal with patients with rare diseases. This dream has become true with JuliaOmix™, an innovative suite projected to make the diagnosis of rare diseases faster. In a growing...
Omzey was founded in 2017.
Omzey is headquartered in Italy.
Omzey operates in AI, Biotechnology and Health Care.
Omzey has approximately 31 employees.
Omzey has completed 7 funding rounds, raising a total of $3.62M. The latest funding stage is Convertible Note.

We're actively collecting intelligence on Omzey.

Source: BounceWatch company record for Omzey, https://bouncewatch.com/company/omzey, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes